Shire plcSHPG announced that the Court of Appeals of the Federal Circuit (CAFC) has affirmed a ruling by the U.S. District Court for the District of New Jersey regarding the validity of patents protecting the active ingredient in Shire’s
Shire's (SHPG) Vyvanse U.S. Patent Validated, Expiry in 2023
